You are here

Calista Therapeutics, Inc.

Company Information
Address 32 Riverside Drive
Lincoln, RI, 02865-1511


Information

DUNS: 078513201

# of Employees: 1


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment

    Amount: $224,550.00

    DESCRIPTION (provided by applicant): Calista Therapeutics has invented Calcaftor, a first-in-class peptide drug that can treat all Cystic Fibrosis (CF) patients. Calcaftor is validated in the gold sta ...

    SBIRPhase I2014Department of Health and Human Services
  2. An Automated Platform for High-throughput Network Electrophysiology

    Amount: $224,993.00

    DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cy ...

    SBIRPhase I2013Department of Health and Human Services
US Flag An Official Website of the United States Government